Boxiong Tang, Sr. Director, GHEOR TEVA
Dr. Tang is the Senior Director and Head of Growth Markets, Global Health Economics and Outcomes Research (GHEOR) at Teva Pharmaceutical, responsible for health outcomes research in developing countries and Asia region. Dr. Tang has established the newly created Growth Markets Market Access and HEOR team within Teva. Previous, Dr. Tang was a Senior Director of Health Outcomes Research at Pfizer Emerging Markets supporting Asia region. His responsibilities include developing and implementing research strategies in clinical development (specialized in health economics assessment and patient reported outcomes, product value dossiers), and post market products (real world and large database creation and analysis). Dr. Tang is specialized in therapeutic areas of oncology, hematology, and immunology (biologics), and women’s health.
He is also an adjuvant professor of China Fudan University, adjuvant faculty of Zhejiang University Medical School, and Scholar of School of Population Health, Thomas Jefferson University. Meanwhile, Dr. Tang is the current Chair of the Health Technology (Industry) Committee, Asia Consortium of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR).
Dr. Tang’s training includes a medical degree in Preventive Medicine, PhD in Health Services Research, and MPH in Health Planning and International Health.